Back to ABIVAXInsider 
Company
Corinna zur Bonsen-Thomas — ABIVAX
Filing 2025DD1072558Published 3 Dec 2025France public disclosures
InitialEffective
Some fields could not be normalized
Part of this filing could not be matched to a trusted normalization rule. Values shown for the affected fields may be approximate or unmapped, and remain as the source reported them.
Affected categories and fields
Instrument type
- Unspecified field
- Unspecified field
Summary
Corinna zur Bonsen-Thomas
Director
ABIVAX
Last 12 months
- Transactions
- Not available
- Total reported value
- Not available
CompanyABIVAX
ISINFR0012333284
Last 12 months
- Transactions
- Not available
- Total reported value
- Not available
Reported buys
€0.00
Reported sales
€1,401,993.48
Net buy/sell
-€1,401,993.48
Other reported value
€0.00
Gross reported value
€1,401,993.48
Transactions
2
Transactions
| Execution date | Direction | Nature | Instrument | Settlement | Quantity | Unit price | Total | Venue |
|---|---|---|---|---|---|---|---|---|
| 4 Nov 2025 | SellCession / SELL | DISPOSAL | SHARE | UNKNOWN | 8,400 | €84.74 | €711,813.48 | XPAR |
| 2 Nov 2025 | SellCession / SELL | DISPOSAL | SHARE | UNKNOWN | 8,000 | €86.27 | €690,180.00 | XPAR |
Sell
Execution date4 Nov 2025Cession / SELL
DISPOSAL · SHARE · UNKNOWN · XPAR
- Quantity
- 8,400
- Unit price
- €84.74
- Total
- €711,813.48
Sell
Execution date2 Nov 2025Cession / SELL
DISPOSAL · SHARE · UNKNOWN · XPAR
- Quantity
- 8,000
- Unit price
- €86.27
- Total
- €690,180.00
Evidence
- AMF · France2025DD1072558
Corrections
Identify the affected field and a source that supports the correction. Use the private contact for rights requests; do not attach identity documents unless necessary and requested.